ASSESSMENT OF HEALTH INFORMATION LITERACY OF NIGERIANS ON THE PREVENTIVE MEASURES OF COVID 19 PANDEMIC: A CROSS SECTIONAL ONLINE SURVEY

The study assessed the health information literacy level of Nigerian on the preventive measures and management of COVID 19 pandemic using online cross sectional survey. The research design adopted for the study is descriptive survey research design. Nigerians between the age of 15 and above made up the population of the study. Online survey using Google form was conducted between using social media platforms. To assess the health information literacy level of Nigerians on the preventive measures of COVID-19; a 25 objective questions constructed by the researcher called “COVID-19 Health Related Information Literacy Assessment Scale” was used. Data collected was analyzed using frequency distribution table and percentage. The null hypotheses one was tested using Mann Whitney U, while the hypothesis two was tested using Kruskal Wallis Test at 0.05 significance level. The computation and analysis of the data collected was performed with the aid of SPSS version 23. The study revealed that, the major sources of information for COVID-19 related health information among Nigerians are social media (facebook, twitter, whatsapp etc.), friends and family, radio programmes. the COVID-19 health literacy level of Nigerians is moderate. Though many scored high in the scale used, most of the respondents are incorrect in most of the advance questions such as recommended meter for social distancing, most appropriate way to wear face shield, contracting COVID-19 through books, spoons, plates among others touched by infected person, and even what to do after coughing or sneezing during COVID-19 among other technical and advance questions. Gender was not a significant factor in the COVID-19 Health Information Literacy Level of Nigerians on the preventive measures of COVID 19 pandemic; while there was a significant difference in the health information literacy level of Nigerians on the preventive measures of COVID 19 pandemic according to educational level, as Nigerians with higher level of education had higher COVID-19 Health Information Literacy level than those with lower educational level. The study recommended among other things that, Federal government should adopt more proactive measures of education Nigerians on the advanced ways to prevent and manage COVID-19. Also, in order to reach wider audience with little or no cost the government should mandate churches and mosques to devote few minutes for enlightening and educating their members on the global best practice in the prevention and management of COVID-1

Sero-Detection of Avian Influenza A/H7 in Nigerian Live-Bird Markets in Plateau State

Avian influenza has been reported in domestic birds in Nigeria since 2006 and subtype H5 of the Gs/Gg lineage has continued to be detected up till date. It has been suggested that waterfowls and local birds sold in live-bird markets may be natural reservoir and source of reinfection of different subtype of avian influenza in poultry farms. This study aims at serodetection of avian influenza virus in waterfowls and local birds at live-bird markets in Plateau State, Nigeria. A total of three hundred and nine (309) blood samples were  collected over a period of three months and two hundred and ninety-two (292) sera were analysed by c-ELISA for influenza A nucleoprotein using standard protocols. Haemagglutination Inhibition (HI) specific for subtypes H5, H9, and H7 was also carried out using standard protocols on ELISA positive samples. The results showed seroprevalence of 5.14% (n=15) for influenza A. Serotype H7 was thereafter detected by HI in 5 of the 15 influenza A positive samples. The H7 positive sera also reacted with H7N3, H7N4, H7N1 and H7N7 virus strains with HI titre ranging between 1:32 to 1:512. This investigation for the first time showed serological evidence of influenza A subtype H7 in local birds and waterfowls sold at the live bird market in Nigeria. Further virological surveillance to isolate the virus is important in order to better understand influenza virus epidemiology in Nigeria and the potential risk that other subtypesof influenza poses to poultry production and public health. Keywords: Influenza A, subtype H7, serological detection, live bird market, Nigeria

Lessons to be learnt from Leishmania studies

Leishmaniasis is a disease caused by infection with the protozoan parasite Leishmania, which is responsible for three main types of disease: cutaneous leishmaniasis, visceral leishmaniasis and mucocutaneous leishmaniasis based to the site of infection for the particular species. This presents a major challenge to successful drug treatment, as a drug must not only reach antileishmanial concentrations in infected macrophages, the parasites' host cell, but also reach infected cells in locations specific to the type of disease. In this paper we discuss how studies using Leishmania have contributed to our knowledge on how drug delivery systems can be used to improve drug efficacy and delivery

Vaccines for the Leishmaniases: Proposals for a Research Agenda

The International Symposium on Leishmaniasis Vaccines, held in Olinda, Brazil, on March 9–11, 2009, congregated international experts who conduct research on vaccines against the leishmaniases. The questions that were raised during that meeting and the ensuing discussions are compiled in this report and may assist in guiding a research agenda. A group to further discussion on issues raised in this policy platform has been set up at http://groups.google.com/group/leishvaccines-l

Deficiency of Leishmania phosphoglycans influences the magnitude but does not affect the quality of secondary (memory) anti-Leishmania immunity

Despite inducing very low IFN-γ response and highly attenuated in vivo, infection of mice with phosphoglycan (PG) deficient Leishmania major (lpg2-) induces protection against virulent L. major challenge. Here, we show that mice infected with lpg2- L. major generate Leishmania-specific memory T cells. However, in vitro and in vivo proliferation, IL-10 and IFN-γ production by lpg2- induced memory cells were impaired in comparison to those induced by wild type (WT) parasites. Interestingly, TNF recall response was comparable to WT infected mice. Despite the impaired proliferation and IFN-γ response, lpg2- infected mice were protected against virulent L. major challenge and their T cells mediated efficient infection-induced immunity. In vivo depletion and neutralization studies with mAbs demonstrated that lpg2- L. major-induced resistance was strongly dependent on IFN-γ, but independent of TNF and CD8(+) T cells. Collectively, these data show that the effectiveness of secondary anti-Leishmania immunity depends on the quality (and not the magnitude) of IFN-γ response. These observations provide further support for consideration of lpg2- L. major as a live-attenuated candidate for leishmanization in humans since it protects strongly against virulent challenge, without inducing pathology in infected animals

Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection

Visceral leishmaniasis (VL), a vector-transmitted disease caused by Leishmania donovani, is potentially fatal if left untreated. Vaccination against VL has received limited attention compared with cutaneous leishmaniasis, although the need for an effective vaccine is pressing for the control of the disease. Earlier, we observed protective efficacy using leishmanial antigen (Ag) in the presence of either cationic liposomes or monophosphoryl lipid A-trehalose dicorynomycolate (MPL-TDM) against experimental VL through the intraperitoneal (i.p.) route of administration in the mouse model. However, this route of immunization is not adequate for human use. For this work, we developed vaccine formulations combining cationic liposomes with MPL-TDM using recombinant GP63 (rGP63) as protein Ag through the clinically relevant subcutaneous (s.c.) route. Two s.c. injections with rGP63 in association with cationic liposomes and MPL-TDM showed enhanced immune responses that further resulted in high protective levels against VL in the mouse model. This validates the combined use of MPL-TDM as an immunopotentiator and liposomes as a suitable vaccine delivery system

TLR4 and NKT Cell Synergy in Immunotherapy against Visceral Leishmaniasis

NKT cells play an important role in autoimmune diseases, tumor surveillance, and infectious diseases, providing in most cases protection against infection. NKT cells are reactive to CD1d presented glycolipid antigens. They can modulate immune responses by promoting the secretion of type 1, type 2, or immune regulatory cytokines. Pathogen-derived signals to dendritic cells mediated via Toll like Receptors (TLR) can be modulated by activated invariant Natural Killer T (iNKT) cells. The terminal β-(1–4)-galactose residues of glycans can modulate host responsiveness in a T helper type-1 direction via IFN-γ and TLRs. We have attempted to develop a defined immunotherapeutic, based on the cooperative action of a TLR ligand and iNKT cell using a mouse model of visceral leishmaniasis. We evaluated the anti-Leishmania immune responses and the protective efficacy of the β-(1–4)-galactose terminal NKT cell ligand glycosphingophospholipid (GSPL) antigen of L. donovani parasites. Our results suggest that TLR4 can function as an upstream sensor for GSPL and provoke intracellular inflammatory signaling necessary for parasite killing. Treatment with GSPL was able to induce a strong effective T cell response that contributed to effective control of acute parasite burden and led to undetectable parasite persistence in the infected animals. These studies for the first time demonstrate the interactions between a TLR ligand and iNKT cell activation in visceral leishmaniasis immunotherapeutic

TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)

Leishmania (Viannia) are the predominant agents of leishmaniasis in Latin America. Given the fact that leishmaniasis is a zoonosis, eradication is unlikely; a vaccine could provide effective prevention of disease. However, these parasites present a challenge and we do not fully understand what elements of the host immune defense prevent disease. We examined the ability of vaccination to protect against L. (Viannia) infection using the highly immunogenic heterologous prime-boost (DNA-modified vaccinia virus) modality and a single Leishmania antigen (TRYP). Although this mode of vaccination can induce protection against other leishmaniases (cutaneous, visceral), no protection was observed against L. (V.) panamensis. However, we found that if the vaccination was modified and the innate immune response was activated through Toll-like receptor1/2(TLR1/2) during the DNA priming, vaccinated mice were protected. Protection was dependent on CD8 T cells. Vaccinated mice had higher CD8 T cell responses and decreased levels of cytokines known to promote infection. Given the long-term persistence of CD8 T cell memory, these findings are encouraging for vaccine development. Further, these results suggest that modulation of TLR1/2 signaling could improve the efficacy of DNA-based vaccines, especially where CD8 T cell activation is critical, thereby contributing to effective and affordable anti parasitic vaccines